Key Takeaways & Executive Findings
- •• • PROTACs exhibit high molecular weight and poor bioavailability, which limit passive tumor accumulation; nanoencapsulation addresses these by improving solubility and stability, potentially increasing intratumoral drug exposure by orders of magnitude compared to free PROTACs. • • Nanocarriers enable spatiotemporally controlled release via passive (EPR effect) or active targeting, reducing systemic toxicity; this is critical because off-tumor PROTAC activity can degrade healthy tissue proteins, leading to dose-limiting toxicities. • • The integration of PROTACs with nanotechnology facilitates synergistic combination therapies, e.g., with radiotherapy or immunotherapy, potentially overcoming acquired resistance mechanisms such as target mutation and pathway rewiring. • • Clinical translation of nano-PROTACs faces scalability and manufacturing challenges, including batch-to-batch reproducibility and long-term stability; however, the platform's modularity supports personalized targeting ligands, aligning with precision oncology paradigms.
Abstract
Conventional cancer therapies remain constrained by undruggable oncogenic proteins and acquired resistance. Proteolysis targeting chimeras (PROTACs) have emerged as a transformative modality that harnesses the ubiquitin-proteasome system to selectively degrade target proteins, offering advantages over traditional small-molecule inhibitors. However, clinical translation of PROTACs is impeded by intrinsic physicochemical limitations: high molecular weight, poor bioavailability, and lack of tumor-specific delivery. Integrating PROTACs with nanotechnology has yielded advanced nano-PROTACs platforms. Nanocarriers enhance solubility and stability, optimize pharmacokinetics, and enable spatiotemporally controlled drug release through passive or active targeting. This review systematically summarizes recent advances in engineering multifunctional nano-PROTACs for cancer therapy, with particular emphasis on design strategies by which nanoengineering enhances PROTAC performance. We evaluate how these platforms improve anticancer efficacy and minimize systemic toxicity while exploring their therapeutic potential in monotherapy and synergistic treatment settings. Finally, we discuss current challenges and future perspectives, providing a theoretical and technical foundation for next-generation nano-PROTACs as a precise and potent strategy in precision oncology.
1. Introduction
Systemic anticancer therapies have advanced with molecularly targeted agents and immunotherapies, yet durable clinical benefit remains limited. A major obstacle is that many disease-relevant proteins lack suitable binding pockets or catalytic domains, rendering them undruggable by conventional small molecules. Even when actionable targets exist, acquired resistance—via target mutation, pathway rewiring, or adaptive signaling—compromises therapeutic responses. PROTACs offer a paradigm shift by inducing selective degradation of target proteins through the ubiquitin-proteasome system, potentially overcoming resistance. However, their clinical translation is stalled by high molecular weight, poor membrane permeability, and rapid clearance, which necessitate high doses and cause off-target effects.
Nanotechnology addresses these bottlenecks by encapsulating PROTACs in carriers that enhance solubility, stability, and pharmacokinetics. Nano-PROTACs can exploit the enhanced permeability and retention (EPR) effect for passive tumor targeting or be functionalized with ligands for active targeting, enabling spatiotemporally controlled release. This review systematically examines design strategies for multifunctional nano-PROTACs, evaluates their efficacy in monotherapy and synergistic settings, and discusses challenges in scalability, safety, and regulatory approval. By integrating material science with cancer biology, nano-PROTACs represent a precise and potent strategy for precision oncology.
Loading authentic research manuscript (Pages 1–5)...
NING Yingyi, WU Yuanhao, SU Linzhu, LIU Jianfeng, HUANG Fan (2026). Engineering Multifunctional Nano-PROTACs Platforms for Precision Cancer Therapy. SCIENCE CHINA Materials. https://doi.org/10.1007/s40843-026-4383-8
Research & Educational Purpose Only: The translations, structured abstracts, analytical annotations, and data reports provided by SinoGreenTechare intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoGreenTech claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are the primary failure mechanisms of free PROTACs under physiological stress, and how do nano-PROTACs mitigate them?
Free PROTACs suffer from poor aqueous solubility, rapid renal clearance, and enzymatic degradation, leading to low intratumoral bioavailability. Nanoencapsulation shields the PROTAC from degradation, improves circulation half-life, and enables controlled release, thereby enhancing target protein degradation efficiency.
How does the cost of nano-PROTAC manufacturing compare to conventional small-molecule inhibitors, and what are the scalability bottlenecks?
Nano-PROTAC manufacturing involves complex multi-step synthesis, purification, and formulation, driving costs significantly higher than small-molecule inhibitors. Scalability is hindered by batch-to-batch variability, sterility requirements, and the need for specialized equipment for nanoparticle production. However, modular design and continuous flow chemistry may reduce costs at scale.
What are the critical quality attributes (CQAs) for nano-PROTACs to ensure consistent efficacy and safety?
CQAs include particle size (typically 50–200 nm for EPR effect), polydispersity index (<0.2), zeta potential (near neutral to slightly negative for prolonged circulation), drug loading efficiency (>10% w/w), and release kinetics (sustained over 24–72 h). These parameters must be tightly controlled to ensure reproducible pharmacokinetics and biodistribution.
How can nano-PROTACs overcome acquired resistance to conventional targeted therapies?
Nano-PROTACs degrade the target protein entirely, eliminating both its catalytic and scaffolding functions, which can circumvent resistance mutations that only affect inhibitor binding. Additionally, co-delivery of PROTACs with other therapeutics (e.g., kinase inhibitors) in a single nanocarrier can suppress compensatory signaling pathways, delaying resistance emergence.
What are the regulatory challenges for nano-PROTACs, and how might they be addressed?
Regulatory agencies lack specific guidelines for combination products that are both nanomedicine and protein degraders. Challenges include characterization of complex formulations, demonstration of batch consistency, and long-term safety of nanomaterials. Early engagement with regulators and use of standardized assays for physicochemical characterization and immunotoxicity are essential.
Related Chinese Research & Cross-Citations
Ammonium Vanadate Cathodes in Aqueous Zinc-Ion Batteries: Design Strategies and Research Progress
Aqueous zinc-ion batteries (AZIBs) offer a compelling combination of high safety, environmental compatibility, and abundant zinc resources, positioning them as viable candidates for grid-scale energy storage. Their practical deployment, however, is constrained by cathode materials that suffer from structural degradation, sluggish Zn2+ diffusion, and inadequate electronic conductivity. Ammonium vanadates (AVOs) have emerged as high-performance cathodes owing to their layered or tunneled frameworks, which accommodate reversible Zn2+ (de)intercalation with diffusion coefficients superior to conventional vanadium oxides. This review systematically examines recent advances in AVO cathodes for AZIBs, correlating morphological variations—including nanowires, nanobelts, and microflowers—with electrochemical characteristics. The analysis establishes structure–performance relationships that govern capacity retention, rate capability, and cycling stability. Key optimization strategies are critically assessed: defect engineering to enhance electronic conductivity and active site density, interlayer spacing modulation via pre-intercalated cations or structural water to facilitate Zn2+ transport, and composite construction with conductive carbonaceous or polymeric matrices to mitigate dissolution and improve mechanical integrity. Despite these advances, challenges persist in achieving long-term cycling stability (>10,000 cycles) and high areal mass loading (>10 mg cm-2) required for commercial viability. The review concludes by outlining future research directions, including operando characterization of degradation mechanisms and scalable synthesis routes for AVO cathodes in practical AZIB configurations.
Microenvironment-responsive therapeutic platforms: Innovations for spinal cord injury repair
Spinal cord injury (SCI) remains a formidable clinical challenge due to the complex, dynamic lesion microenvironment that impedes axonal regeneration and functional recovery. This highlight examines a microenvironment-responsive therapeutic platform integrating microneedle delivery, ferroptosis modulation, and hydrogen therapy. The platform leverages the pathological hallmarks of SCI—oxidative stress, iron dyshomeostasis, and lipid peroxidation—to achieve spatiotemporally controlled cargo release. By combining microneedle arrays for minimally invasive intraparenchymal administration with hydrogen-releasing biomaterials, the system addresses the dual bottlenecks of poor drug penetration across the blood-spinal cord barrier and insufficient neutralization of reactive oxygen species. Ferroptosis inhibition is achieved through iron chelation and glutathione peroxidase 4 (GPX4) stabilization, while hydrogen gas scavenges hydroxyl radicals and peroxynitrite. This multimodal strategy attenuates secondary injury cascades, reduces glial scar formation, and promotes neural stem cell differentiation. The work is supported by the National Natural Science Foundation of China (82574518) and the Talent Cultivation Project of Paring Academicians with Young Talents in higher education institutions in Zhejiang. The authors declare no conflict of interest. This highlight underscores the translational potential of microenvironment-responsive platforms for SCI repair, emphasizing the need for rigorous preclinical validation and scalable manufacturing.
Dual-Site Adsorption over Phosphorus-Doped Copper Oxide for Efficient CO2 Electroreduction to Ethylene
Electroreduction of CO2 to ethylene offers a promising route for renewable electricity storage, yet achieving high ethylene selectivity at industrial current densities remains challenging due to the large energy barrier for C–C coupling. Here, we report a “MOF-assisted in situ doping” strategy to introduce the oxophilic nonmetal phosphorus (P) into the copper oxide (CuO) lattice, constructing a localized Cu–P dual-site adsorption configuration for the key *OCCHO intermediate. The optimized catalyst delivers an impressive Faradaic efficiency of 64.6% for ethylene with a partial current density of 646 mA cm-2. Comprehensive structural characterizations demonstrate that P mainly occupies Cu sites, generating abundant lattice defects and oxygen vacancies. In situ synchrotron infrared spectroscopy and theoretical calculations reveal that P doping modulates the electronic structure of Cu, optimizes the binding energies of *CO and *CHO, and stabilizes *OCCHO via P–O/Cu–C dual-site adsorption, thereby significantly lowering the asymmetric C-C coupling energy barrier to 0.74 eV. This work highlights a dual-site microenvironment regulation strategy for CO2-to-ethylene electroreduction.
Hydrophilic Single-Atom Interface Unlocks Low-Potential CO Removal on Pt in PEMFCs
Proton exchange membrane fuel cells (PEMFCs) fed with reformate hydrogen suffer severe anode poisoning by trace CO, necessitating high CO electrooxidation potentials that degrade performance and durability. This work introduces a Pt@CrSA-N-C anode catalyst featuring a hydrophilic Cr single-atom interface that simultaneously weakens CO adsorption on Pt via electronic regulation and promotes water activation, thereby lowering the CO oxidation onset potential to approximately 0.13 V vs. RHE. The onset potential was determined by two independent methods: the first potential at which the background-corrected current exceeds 0 mA cm-2 during CO oxidation reaction tests in a three-electrode system, and the potential at which the forward scan current exceeds the N2 background current in CO-stripping voltammetry. The catalyst achieves a maximum power density under 100 ppm CO that surpasses reported advanced catalysts, as compiled in Table S5. Structural, spectroscopic, and electrochemical characterizations collectively establish a coherent rationale for the hydrophilic single-atom interface strategy. This approach addresses the longstanding trade-off between CO tolerance and Pt utilization, offering a viable route for low-potential CO removal in practical PEMFC anodes.
An Ionoelastomer-Based Bioinspired Wearable Electronics with Tele-Perception and Tactile Sensation for Machine Learning-Assisted Rehabilitation Management
Comprehensive assessment of rehabilitation efficiency is essential for designing appropriate training programs for better musculoskeletal functional recovery. Existing contact-receptor-dependent rehabilitation assessment systems mostly focus on assessing the restoration of muscle function by evaluating grip strength or joint flexion angle; however, parameters reflecting neuromuscular synergistic function are always overlooked. Herein, we develop an ionoelastomer-based soft artificial electroreceptor (SAER) that integrates tele-perception and tactile sensation to track the rehabilitation process, collecting signals related to approaching speed and grip strength sequentially. The SAER uses polyurethane ionoelastomer incorporated with quasi-solid conductive salt as the electric field receptor, and is integrated on a rehabilitation-training ball after assembly to establish an untethered detection device; this enables the remote capture of hand approaching parameter within a 9 cm range, followed by the quantification of grip strength when contacting and grasping. Furthermore, a data-driven assessment system is established by integrating machine learning, which accurately classifies rehabilitation efficiency into six levels; it supports for rehabilitation evaluation and training programs adjustment. Overall, the SAER-based rehabilitation management system establishes a paradigm that synergistically evaluating parameters corresponding to neuromuscular functional restoration and holds strong potential for home-based active rehabilitation for minimizing dependence on frequent clinical supervision.
Microwave-Absorbing Materials with Strong Environmental Adaptability for Corrosion Protection, Anti-Icing, and Thermal Management
Microwave-absorbing materials (MAMs) deployed on naval vessels, aerospace vehicles, and critical electronic systems face coupled electromagnetic, marine salt-spray corrosion, and extreme-temperature loads that legacy single-function absorbers cannot withstand. This review consolidates progress on three environmentally adaptive MAM classes: corrosion-protective, anti-icing, and thermal-management absorbers. The electromagnetic loss and impedance-matching fundamentals are first established, then the synergistic mechanisms, design strategies, and characterization protocols for each class are examined against representative material systems and their measured performance. The analysis identifies a shared design logic—multiscale hierarchical architecture, interfacial polarization engineering, and multifunctional phase integration—while distinguishing the divergent protection mechanisms: barrier and passivation effects for corrosion, surface-energy and latent-heat regulation for anti-icing, and phonon–electron transport decoupling for thermal management. Persistent bottlenecks include the trade-off between impedance matching and protective-layer density, the absence of standardized coupled-field test protocols, and the scarcity of long-term salt-spray and thermal-cycling durability data. Future directions are delineated: intelligent self-adaptive absorbers, multiphysics-coupled simulation frameworks, and environmentally benign multifunctional integration. The review provides a theoretical and technical basis for the design, construction, and engineering scale-up of next-generation high-performance absorbers for aerospace, electronic, and marine equipment.